Public health relevance of drug–nutrition interactions

Szabolcs Péter, Gerjan Navis, Martin H. de Borst, Clemens von Schacky, Anne Claire B. van Orten-Luiten, Alexandra Zhernakova, Renger F. Witkamp, André Janse, Peter Weber, Stephan L.J. Bakker, Manfred Eggersdorfer

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

The public health relevance of drug–nutrition interactions is currently highly undervalued and overlooked. This is particularly the case for elderly persons where multi-morbidity and consequently polypharmacy is very common. Vitamins and other micronutrients have central functions in metabolism, and their interactions with drugs may result in clinically relevant physiological impairments but possibly also in positive effects. On 12 April 2016, the University Medical Center Groningen (The Netherlands), as part of its Healthy Ageing program, organized a workshop on the public health relevance of drug–nutrient interactions. In this meeting, experts in the field presented results from recent studies on interactions between pharmaceuticals and nutrients, and discussed the role of nutrition for elderly, focusing on those persons receiving pharmaceutical treatment. This paper summarizes the proceedings of the symposium and provides an outlook for future research needs and public health measures. Since food, pharma and health are closely interconnected domains, awareness is needed in the medical community about the potential relevance of drug–nutrition interactions. Experts and stakeholders should advocate for the integration of drug–nutrition evaluations in the drug development process. Strategies for the individual patients should be developed, by installing drug review protocols, screening for malnutrition and integrating this topic into the general medical advice.
LanguageEnglish
Pages23-36
JournalEuropean Journal of Nutrition
Volume56
Issue numbersuppl. 2
DOIs
Publication statusPublished - 2017

Fingerprint

Drug Interactions
Public Health
Food
Pharmaceutical Preparations
Polypharmacy
Drug Evaluation
Micronutrients
Vitamins
Malnutrition
Netherlands
Morbidity
Education
Health
Therapeutics

Keywords

  • Drug–nutrient interactions
  • Health benefits
  • Microbiota
  • Micronutrient deficiency
  • Public health

Cite this

Péter, S., Navis, G., de Borst, M. H., von Schacky, C., van Orten-Luiten, A. C. B., Zhernakova, A., ... Eggersdorfer, M. (2017). Public health relevance of drug–nutrition interactions. European Journal of Nutrition, 56(suppl. 2), 23-36. https://doi.org/10.1007/s00394-017-1510-3
Péter, Szabolcs ; Navis, Gerjan ; de Borst, Martin H. ; von Schacky, Clemens ; van Orten-Luiten, Anne Claire B. ; Zhernakova, Alexandra ; Witkamp, Renger F. ; Janse, André ; Weber, Peter ; Bakker, Stephan L.J. ; Eggersdorfer, Manfred. / Public health relevance of drug–nutrition interactions. In: European Journal of Nutrition. 2017 ; Vol. 56, No. suppl. 2. pp. 23-36.
@article{e63aef0fead64dbc905c8c1a025f3034,
title = "Public health relevance of drug–nutrition interactions",
abstract = "The public health relevance of drug–nutrition interactions is currently highly undervalued and overlooked. This is particularly the case for elderly persons where multi-morbidity and consequently polypharmacy is very common. Vitamins and other micronutrients have central functions in metabolism, and their interactions with drugs may result in clinically relevant physiological impairments but possibly also in positive effects. On 12 April 2016, the University Medical Center Groningen (The Netherlands), as part of its Healthy Ageing program, organized a workshop on the public health relevance of drug–nutrient interactions. In this meeting, experts in the field presented results from recent studies on interactions between pharmaceuticals and nutrients, and discussed the role of nutrition for elderly, focusing on those persons receiving pharmaceutical treatment. This paper summarizes the proceedings of the symposium and provides an outlook for future research needs and public health measures. Since food, pharma and health are closely interconnected domains, awareness is needed in the medical community about the potential relevance of drug–nutrition interactions. Experts and stakeholders should advocate for the integration of drug–nutrition evaluations in the drug development process. Strategies for the individual patients should be developed, by installing drug review protocols, screening for malnutrition and integrating this topic into the general medical advice.",
keywords = "Drug–nutrient interactions, Health benefits, Microbiota, Micronutrient deficiency, Public health",
author = "Szabolcs P{\'e}ter and Gerjan Navis and {de Borst}, {Martin H.} and {von Schacky}, Clemens and {van Orten-Luiten}, {Anne Claire B.} and Alexandra Zhernakova and Witkamp, {Renger F.} and Andr{\'e} Janse and Peter Weber and Bakker, {Stephan L.J.} and Manfred Eggersdorfer",
year = "2017",
doi = "10.1007/s00394-017-1510-3",
language = "English",
volume = "56",
pages = "23--36",
journal = "European Journal of Nutrition",
issn = "1436-6207",
publisher = "Springer Verlag",
number = "suppl. 2",

}

Péter, S, Navis, G, de Borst, MH, von Schacky, C, van Orten-Luiten, ACB, Zhernakova, A, Witkamp, RF, Janse, A, Weber, P, Bakker, SLJ & Eggersdorfer, M 2017, 'Public health relevance of drug–nutrition interactions', European Journal of Nutrition, vol. 56, no. suppl. 2, pp. 23-36. https://doi.org/10.1007/s00394-017-1510-3

Public health relevance of drug–nutrition interactions. / Péter, Szabolcs; Navis, Gerjan; de Borst, Martin H.; von Schacky, Clemens; van Orten-Luiten, Anne Claire B.; Zhernakova, Alexandra; Witkamp, Renger F.; Janse, André; Weber, Peter; Bakker, Stephan L.J.; Eggersdorfer, Manfred.

In: European Journal of Nutrition, Vol. 56, No. suppl. 2, 2017, p. 23-36.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Public health relevance of drug–nutrition interactions

AU - Péter, Szabolcs

AU - Navis, Gerjan

AU - de Borst, Martin H.

AU - von Schacky, Clemens

AU - van Orten-Luiten, Anne Claire B.

AU - Zhernakova, Alexandra

AU - Witkamp, Renger F.

AU - Janse, André

AU - Weber, Peter

AU - Bakker, Stephan L.J.

AU - Eggersdorfer, Manfred

PY - 2017

Y1 - 2017

N2 - The public health relevance of drug–nutrition interactions is currently highly undervalued and overlooked. This is particularly the case for elderly persons where multi-morbidity and consequently polypharmacy is very common. Vitamins and other micronutrients have central functions in metabolism, and their interactions with drugs may result in clinically relevant physiological impairments but possibly also in positive effects. On 12 April 2016, the University Medical Center Groningen (The Netherlands), as part of its Healthy Ageing program, organized a workshop on the public health relevance of drug–nutrient interactions. In this meeting, experts in the field presented results from recent studies on interactions between pharmaceuticals and nutrients, and discussed the role of nutrition for elderly, focusing on those persons receiving pharmaceutical treatment. This paper summarizes the proceedings of the symposium and provides an outlook for future research needs and public health measures. Since food, pharma and health are closely interconnected domains, awareness is needed in the medical community about the potential relevance of drug–nutrition interactions. Experts and stakeholders should advocate for the integration of drug–nutrition evaluations in the drug development process. Strategies for the individual patients should be developed, by installing drug review protocols, screening for malnutrition and integrating this topic into the general medical advice.

AB - The public health relevance of drug–nutrition interactions is currently highly undervalued and overlooked. This is particularly the case for elderly persons where multi-morbidity and consequently polypharmacy is very common. Vitamins and other micronutrients have central functions in metabolism, and their interactions with drugs may result in clinically relevant physiological impairments but possibly also in positive effects. On 12 April 2016, the University Medical Center Groningen (The Netherlands), as part of its Healthy Ageing program, organized a workshop on the public health relevance of drug–nutrient interactions. In this meeting, experts in the field presented results from recent studies on interactions between pharmaceuticals and nutrients, and discussed the role of nutrition for elderly, focusing on those persons receiving pharmaceutical treatment. This paper summarizes the proceedings of the symposium and provides an outlook for future research needs and public health measures. Since food, pharma and health are closely interconnected domains, awareness is needed in the medical community about the potential relevance of drug–nutrition interactions. Experts and stakeholders should advocate for the integration of drug–nutrition evaluations in the drug development process. Strategies for the individual patients should be developed, by installing drug review protocols, screening for malnutrition and integrating this topic into the general medical advice.

KW - Drug–nutrient interactions

KW - Health benefits

KW - Microbiota

KW - Micronutrient deficiency

KW - Public health

U2 - 10.1007/s00394-017-1510-3

DO - 10.1007/s00394-017-1510-3

M3 - Article

VL - 56

SP - 23

EP - 36

JO - European Journal of Nutrition

T2 - European Journal of Nutrition

JF - European Journal of Nutrition

SN - 1436-6207

IS - suppl. 2

ER -